Advertisement

Topics

Search Results for "Xarelto Vs Pradaxa"

20:12 EDT 28th June 2017 | BioPortfolio

Matching Channels

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Matching News

Bristol-Myers and Pfizer's Eliquis outperforms rivals versus warfarin

In a so-called real world study, the anti-coagulant did better in reducing the risk of strokes or major bleeds compared to warfarin than did J&J's competing Xarelto or Boehringer's&nb...

STAT Plus: Pharmalot, Pharmalittle: J&J and Bayer win their first trial over alleged Xarelto harms

A federal court jury found that the companies did not mislead a Louisiana man and his doctors about the health risks of the Xarelto blood thinner.

Pradaxa Beats Warfarin After Heart Rhythm Procedure: Study

MONDAY, March 20, 2017 -- Patients undergoing a surgical procedure to treat an irregular heartbeat are less likely to suffer problematic bleeding when given the blood thinner Pradaxa rather than warfa...

Janssen files sNDA to update Xarelto dosing in PI

A supplemental new drug application has been filed by Janssen seeking to update the prescribing information for Xarelto, or r -More- 

Bayer’s Xarelto beats aspirin in preventing blood clots

Data from a late-stage trial show that Bayer and Janssen’s Xarelto was better than aspirin at protecting patients from recurrent venous thromboembolism.

More Pressure On Pradaxa? US Payers May Narrow Coverage Of NOACs

US payers may increasingly look to leverage the competition among the novel oral anticoagulants by contracting for preferred coverage with...    

Heart trial success will give Xarelto edge

Janssen and Bayer have stopped a phase 3 trial of Xarelto early after results showed it can cut deaths, heart attacks and strokes compared to aspirin. The promising data paves the way for a lucrativ...

J&J and Bayer Win First Xarelto Lawsuit

Bayer and Johnson & Johnson have won the first of around 18,000 lawsuits lawsuit being brought by US patients who claim the blood-thinning drug Xarelto caused their uncontrollable brain and gastro...

Matching PubMed Articles

Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review.

Direct oral anticoagulants (DOACs) are in wide use among patients requiring both short- and long-term anticoagulation, mainly due to their ease of use and the lack of monitoring requirements. With gro...

Drug interaction: dabigatran (Pradaxa) and statins.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement